Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Benitec Biopharma Limited (BNTC) had Debt to Equity Ratio of 0.01 for the most recently reported fiscal year, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
$-22.37M |
|
$-0.11M |
|
$0.11M |
|
$22.49M |
|
$-22.49M |
|
$0.74M |
|
$-21.75M |
|
$-21.75M |
|
$-21.75M |
|
$-21.75M |
|
$-21.75M |
|
$-21.75M |
|
$-22.49M |
|
$-22.40M |
|
4.06M |
|
4.06M |
|
$-5.51 |
|
$-5.51 |
|
| Balance Sheet Financials | |
$51.67M |
|
$0.18M |
|
$0.54M |
|
$52.21M |
|
$4.92M |
|
-- |
|
$0.04M |
|
$4.96M |
|
$47.25M |
|
$47.25M |
|
$47.25M |
|
10.09M |
|
| Cash Flow Statement Financials | |
$-19.40M |
|
$-0.18M |
|
$68.03M |
|
$2.49M |
|
$50.93M |
|
$48.44M |
|
$0.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.49 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
0.01 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-46.04% |
|
-46.04% |
|
-41.66% |
|
-46.04% |
|
$4.68 |
|
$-4.82 |
|
$-4.78 |
|